Head, Clinical Pharmacology & Early Clinical Development, PDT BU
Takeda Development Center Americas, Inc., Cambridge, MA, USA
Cambridge, Massachusetts, United States
Dr. Zhaoyang (Megan) Li, PhD, is currently the Head of Global Clinical Pharmacology & Early Clinical Development in Plasma Derived Therapies Business Unit at Takeda Pharmaceuticals. Her research focuses on clinical development of plasma-derived therapies for various diseases including hematology, primary immune deficiencies, neuro-autoimmune diseases, pulmonary and other rare diseases. She has been working in the biopharmaceutical industry for 25 years.
PB0332 - Pharmacokinetics of protein C in neonates with severe congenital protein C deficiency
Sunday, June 23, 2024
13:45 – 14:45 ICT